Marinomed Biotech AG (VIE:MARI)
Austria · Delayed Price · Currency is EUR 4.500
0.00 (0.00%)
Aug 27, 2026, 1:30 PM CET
Marinomed Biotech AG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.95 | 1.71 | 2.56 | 8.18 | 5.8 |
Cash & Short-Term Investments | 0.95 | 1.71 | 2.56 | 8.18 | 5.8 |
Cash Growth | -44.22% | -33.45% | -68.64% | 40.90% | -36.98% |
Accounts Receivable | 0.18 | 0.42 | 1.78 | 1.39 | 3.4 |
Other Receivables | 0.15 | 0.49 | 0.98 | 1.73 | 1.41 |
Receivables | 0.33 | 0.91 | 2.76 | 3.12 | 4.81 |
Inventory | 0 | 0.54 | 0.89 | 1.56 | 1.03 |
Prepaid Expenses | - | - | - | 1.41 | 1.24 |
Other Current Assets | 0.14 | 0.04 | 0.17 | -0 | 0 |
Total Current Assets | 1.43 | 3.29 | 6.39 | 14.27 | 12.88 |
Property, Plant & Equipment | 4.51 | 4.79 | 5.81 | 6.2 | 6.43 |
Long-Term Investments | - | 0.02 | 0.04 | - | - |
Other Intangible Assets | 0.01 | 0.09 | 0.13 | 0.2 | 0.18 |
Long-Term Deferred Charges | - | - | - | 1.61 | 1.83 |
Other Long-Term Assets | - | - | - | 0.01 | 0.02 |
Total Assets | 5.95 | 8.18 | 12.36 | 22.29 | 21.34 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.16 | 1.69 | 1.53 | 1.15 | 1.99 |
Accrued Expenses | 0.15 | 0.82 | 0.23 | 0.82 | 1.54 |
Current Portion of Long-Term Debt | 5.34 | 28.23 | 7.58 | 2.45 | 0.74 |
Current Portion of Leases | - | - | - | - | 0.02 |
Current Income Taxes Payable | 0.13 | 0.28 | 0.2 | - | - |
Current Unearned Revenue | - | - | - | 0.84 | 1.39 |
Other Current Liabilities | - | 0.47 | 0.08 | 0.7 | 0.34 |
Total Current Liabilities | 5.77 | 31.49 | 9.62 | 5.96 | 6.01 |
Long-Term Debt | 6.22 | 1.04 | 14 | 20.18 | 15.01 |
Long-Term Leases | - | - | - | - | 0.04 |
Long-Term Unearned Revenue | 0.22 | 0.24 | 0.27 | 0.3 | 0.09 |
Other Long-Term Liabilities | 0.78 | 1.57 | 1.07 | - | -0 |
Total Liabilities | 13 | 34.34 | 24.96 | 26.44 | 21.15 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.84 | 1.78 | 1.52 | 1.51 | 1.48 |
Retained Earnings | -52.92 | -70.93 | -54.86 | -49.76 | -43.36 |
Comprehensive Income & Other | 44.03 | 43 | 40.74 | 44.09 | 42.07 |
Shareholders' Equity | -7.05 | -26.16 | -12.6 | -4.16 | 0.19 |
Total Liabilities & Equity | 5.95 | 8.18 | 12.36 | 22.29 | 21.34 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 11.56 | 29.28 | 21.58 | 22.63 | 15.8 |
Net Cash (Debt) | -10.61 | -27.57 | -19.02 | -14.45 | -10 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -5.77 | -15.50 | -12.53 | -9.64 | -6.77 |
Filing Date Shares Outstanding | 1.84 | 1.78 | 1.54 | 1.52 | 1.49 |
Total Common Shares Outstanding | 1.84 | 1.78 | 1.52 | 1.51 | 1.48 |
Working Capital | -4.34 | -28.2 | -3.24 | 8.31 | 6.86 |
Book Value Per Share | -3.83 | -14.71 | -8.27 | -2.76 | 0.13 |
Tangible Book Value | -7.06 | -26.25 | -12.73 | -4.35 | 0.01 |
Tangible Book Value Per Share | -3.84 | -14.76 | -8.35 | -2.89 | 0.01 |
Land | 5.91 | 5.91 | 5.91 | 5.91 | 5.89 |
Machinery | 1.55 | 1.54 | 1.55 | 1.31 | 1.26 |